New York, NY -- (SBWIRE) -- 12/03/2013 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Chinacast Education Corporation (OTCMKTS:CAST), THEDIRECTORY.COM INC (OTCMKTS:SEEK), Merrimack Pharmaceuticals Inc (NASDAQ:MACK), Sprint Corporation (NYSE:S)
Chinacast Education Corporation (OTCMKTS:CAST) showed a volume of 1.04 million shares by the end of last trade whereas the average volume of the stock remained 92,960.00 shares. The stock opened the session at $0.04 but then moved to $0.0500. At that price, the stock showed a positive performance of 12.87%. ChinaCast Education Corporation (CEC) is a post-secondary education and e-Learning services provider in People's Republic of China. The Company provides post-secondary degree and diploma programs through its two universities in China: The Foreign Trade and Business College of Chongqing Normal University and the Lijiang College of Guangxi Normal University.
Will CAST Continue To Move Higher? Find Out Here
THEDIRECTORY.COM INC (OTCMKTS:SEEK) opened the session at $0.001 and closed the session at $0.0037. The stock showed a positive performance of 12.12% in previous trading session. Traded with volume of 57.95 million shares in the prior session and the average volume of the stock remained 131.20 million shares.
For How Long SEEK will fight for Profitability? Read This Trend Analysis report
Merrimack Pharmaceuticals Inc (NASDAQ:MACK) opened the session at $4.04 and closed the session at $4.20. The stock showed a positive performance of 6.60% in previous trading session. Traded with volume of 3.69 million shares in the prior session and the average volume of the stock remained 2.12 million shares. Merrimack Pharmaceuticals, Inc. is a biopharmaceutical company discovering, developing and preparing to commercialize medicines paired with companion diagnostics for the treatment of serious diseases, with an initial focus on cancer. The Company’s product candidates include MM-398, MM-121, MM-111, MM-302 and MM-151. The Company’s Network biology is an interdisciplinary approach to drug discovery and development that enables the Company to build functional and predictive computational models of biological systems based on quantitative, kinetic, multiplexed biological data.
Why Should Investors Buy MACK After The Recent Gain? Just Go Here and Find Out
Sprint Corporation (NYSE:S) the stock decreased -2.26% and finished the session at $8.20. Traded with volume of 16.17 million shares in the prior session and the average volume of the stock remained 19.28 million shares.
Will Sprint Get Buyers Even After The Recent Rally? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)